<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<pubmed-document>
<record>
<header>
<identifier>14429109</identifier>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:author>OROZCO, W</dc:author>
<dc:type>Journal Article</dc:type>
<dc:language>es</dc:language>
<dc:subject>DEPRESSION/therapy</dc:subject>
<dc:subject>IPRONIAZID/related compounds</dc:subject>
<dc:subject>ALCOHOLISM/therapy</dc:subject>
<dc:subject>SCHIZOPHRENIA/therapy</dc:subject>
<dc:date>1960 Mar 25 </dc:date>
<dc:title xml:lang="en">[Nialamide in the treatment of schizophrenic depression and of dipsomania].</dc:title>
<dc:publisher>Revista. Asociacion Medica Mexicana</dc:publisher>
</metadata>
</record>
</pubmed-document>
